To my knowledge, the RO requirement for combo HIV BLA has
To my knowledge, the RO requirement for combo HIV BLA has not been fully addressed publicly which is why the questions continue to be asked.
I am not sure if you misunderstood my response or I am misunderstanding yours, but I was addressing RO as it pertains to the combo HIV trial and impacts on the BLA status. You seem to be discussing RO in COVID. IMO these are two completely separate discussions as leronlimab has a direct impact on R5 tropic HIV by not allowing it to enter the cell, whereas CCR5 has in indirect innate immune response in COVID. I could be wrong, but I view RO less critical in COVID simply due to if 80% RO, then the patient's innate immune response likely improves some degree and allow them to recover (granted the closer to 100% and faster the better), but in HIV 80% RO likely results in a failed result given the virus is likely at a detectable level. Everyone's CCR5 density is different, so a 350mg dose works for some HIV patients while others had detectible levels of HIV at 700mg dose. The RO test would simply best identify what CCR5 densities would respond to what dose level based on the individual's CCR5 density (personalized, precision medicine).
I think we agree on the reasons for trials, but the RO was never part of the combo or mono HIV trial protocol, so that is why so many are concerned and confused when it is mentioned as a reason for the combo HIV BLA delay. If a RO extension trial is needed, then by all means do one, but IMO it should be done as a label expansion trial vs holding up the initial combo HIV BLA and approval that met its PE over two years ago and is much safer and had twice the efficacy as the current drugs approved for MDR2+ patients.
But to circle back around, do we know whether RO is required for combo HIV BLA or not......To my knowledge, the RO requirement for combo HIV BLA has not been fully addressed publicly which is why the questions continue to be asked.
10
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...
Continue Reading
A Rocky Ride for Chemours Investors The ticker might read NYSE:CC, but right now, that might as well stand for "Caution, Cautious," if you ask me. Investors are on high alert with Chemours facing a class action lawsuit, and the stakes couldn’t be higher. Deadline's looming on December 7, 2026, for those gunning for lead plaintiff status. It's a tense time for anyone who...
Continue Reading
Awarding a Military Financial Educator There's something profoundly rewarding when hard work and dedication get their due recognition. That's precisely what's happened for Lacey Langford, who’s just been awarded the Lieutenant Timothy Dix Bolles Excellency in Education Award by the Navy Mutual Aid Association, or simply Navy Mutual. This isn’t just some...
Continue Reading
Millrose Properties: A Storm's Brewing Whoa, step back and take a wide-eyed look at Millrose Properties—there’s a storm brewin’ and it’s a doozy! Right now, they’re up against one mighty class action lawsuit, and investors who’ve been hit for over $100k better circle December 8, 2026, on their calendars if they fancy a shot at lead plaintiff glory. We’re...
Continue Reading
Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...
Continue Reading
Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...
Continue Reading
Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...
Continue Reading
From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...
Continue Reading
New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...
Continue Reading
Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...
Continue Reading
Top 5 Most Recently Viewed Articles
EarthCam Launches AI-Powered Mobile StreamCam Robotic EarthCam, a leader in visual technology, has unveiled its new Mobile StreamCam Robotic aimed at enhancing monitoring capabilities in interior construction. This innovative camera is designed to combine advanced live-streaming features with smart AI insights, providing construction teams with real-time data and...
Continue Reading
Understanding the iLearningEngines Class Action Lawsuit The well-regarded law firm Faruqi & Faruqi, LLP is currently inviting investors of iLearningEngines, Inc. to stay informed about an important class action lawsuit. This lawsuit revolves around allegations that iLearningEngines engaged in misleading practices fundamentally impacting its investors. The deadline to seek...
Continue Reading
Investigation into Elevidys Following a Tragic Incident The U.S. Food and Drug Administration (FDA) has begun an investigation into the unfortunate death of a young boy who was administered Elevidys, Sarepta Therapeutics Inc.’s gene therapy designed for treating Duchenne muscular dystrophy. This announcement came after market close, raising concerns regarding the safety...
Continue Reading
2Rivers Group Expands Operations into West Africa 2Rivers Group is excited to announce its ongoing expansion into the West African market, reinforcing its status as a key entity in the global energy trading and distribution landscape. This initiative aligns perfectly with the company’s vision of achieving sustainable growth in important markets around the world....
Continue Reading
Pathward Financial to Announce Earnings for First Quarter 2025 Pathward Financial, Inc. has made an important announcement regarding its upcoming financial results for the first quarter of fiscal year 2025. The release is set for Tuesday, after the market closes, and the company is eager to share insights from these results. Conference Call Scheduled A conference call and...
Continue Reading
